Voyager Therapeutics Inc
Biotechnology
Healthcare
VYGR
57.85 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.80
52 week high
9.27
high
3.22
52 week low
2.85
low
2.75
growth
-62.98 %
previous Close
2.85
P/E ratio
market cap
316 M
div yield
0
usd
Sep 2024
qoq
revenue
24.63 M
-16.73 %
net incoming
-9.04 M
10.82 %
eps
0.00 %
11.11 %
eps surprise
64.44 %
net profit margin
-36.72 %
-2.00 %
operating incoming
-13.78 M
8.29 %
net change in cash
36.40 M
154.36 %
cash on hand
113 M
47.81 %
cost of revenue
0.00 %
top top